Multicenter, Post-marketing, Non-interventional, Observational Study in RA Patients Treated With RoActemra/Actemra (Tocilizumab)

CompletedOBSERVATIONAL
Enrollment

400

Participants

Timeline

Start Date

July 9, 2014

Primary Completion Date

May 22, 2017

Study Completion Date

May 22, 2017

Conditions
Rheumatoid Arthritis
Trial Locations (25)

100034

Peking University First Hospital, Beijing

100083

Peking University Third Hospital, Beijing

100730

Beijing Union Hospital, Beijing

210029

Nanjing Drum Tower Hospital, the Affiliated Hospital of Nanjing University Medical School, Nanjing

214023

Wuxi People's Hospital, Wuxi

361003

The First Affiliated Hospital of Xiamen University, Xiamen

400038

Southwest Hospital , Third Military Medical University, Chongqing

410008

Xiangya Hospital of Centre-South University, Changsha

430030

Tongji Hosp, Tongji Med. Col, Huazhong Univ. of Sci. & Tech, Wuhan

471003

The First Affiliated Hospital of Henan UN of Science and Technology, Luoyang

510000

Sun Yat-sen Memorial Hospital, Guangzhou

510515

Nanfang Hospital, Southern Medical University, Guangzhou

510630

The First Affiliated Hospital of Jinan University, Guangzhou

610041

West China Hospital, Sichuan University, Chengdu

610072

Sichuan Provincial People's Hospital, Chengdu

650032

The First People's Hospital of Yunnan Province, Kunming

710038

The Second Affiliated Hospital of The Fourth Military Medical University (Tangdu Hospital), Xi'an

830001

Xinjiang Uygur Autonomous Region People Hospital, Ürümqi

Unknown

TCM-Integrated Hospital of Southern Medical University, Guangzhou

Zhejiang People's Hospital, Hangzhou

Affiliated Hospital of Inner Mongolia Medical College, Hohhot

Affiliated Hospital of North Sichuan Medical College, Nanchong

Futian District people's Hospital of Shenzhen City, Shenzhen

YanTaishan Hospital of Yantai City, Yantai

Zhuzhou Central Hospital, Zhuzhou

All Listed Sponsors
lead

Hoffmann-La Roche

INDUSTRY

NCT02101307 - Multicenter, Post-marketing, Non-interventional, Observational Study in RA Patients Treated With RoActemra/Actemra (Tocilizumab) | Biotech Hunter | Biotech Hunter